ReviewCureus2026
Current State of the Art in Neurosurgical Operative Microscopes.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Surgical microscopes play a critical role in neurosurgery, providing high-resolution visualization, magnification, and ergonomic advantages that support precise surgical interventions and enhance the training environment. Recent technological advances have further expanded their clinical value. This study evaluated the current generation of neurosurgical operative microscopes, identifying and comparing the technical specifications, advantages, and limitations of the latest models released by six leading manufacturers: Carl Zeiss Meditec AG (Jena, Germany); Leica Microsystems GmbH (Wetzlar, Germany (a subsidiary of Danaher Corp., Washington, DC); Mitaka Kohki Co., Ltd. (Tokyo, Japan); Olympus Corp. (Tokyo, Japan); Aesculap, Inc. (Tuttlingen, Germany (a subsidiary of B. Braun Group, Melsungen, Germany)); and Synaptive Medical, Inc. (Ontario, Canada). Information was gathered through manufacturer-provided technical data, direct communication with company representatives, and published reports on neurosurgical microscopes. Particular attention was given to models in use worldwide. A total of 21 surgical microscopes and exoscopes from six leading manufacturers were reviewed. Zeiss microscopes, particularly the Kinevo 900 and Pentero series, demonstrated advanced integration with robotic positioning, compatibility with image-guided surgery, and automated movement systems. Leica models were notable for their emphasis on surgical education and training, with systems such as the M320 T microscope, the MyVeo headset, and augmented reality (AR)-enhanced fluorescence modules. Mitaka microscopes were distinguished by their lightweight design and compact stands, offering enhanced mobility in operating rooms with limited space. The specialized exoscope models from Olympus, Aesculap, and Synaptive offered excellent image clarity and ergonomic control. Notably, refurbished older microscopes are often used in low- and middle-income countries due to financial constraints. Contemporary neurosurgical microscopes have evolved into multifunctional platforms that support surgical precision and enhance training, education, and intraoperative visualization. The integration of cutting-edge technologies (e.g., AR visualization, artificial intelligence, robotics, wireless controls, and adaptive viewing platforms) signals a promising path for the future of surgical innovation. However, global variability in model availability reflects underlying resource disparities. Continued innovation and efforts to make advanced technologies more accessible are essential to supporting neurosurgeons worldwide.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.